Wu Hong, Li Lei, Yang Jing, Guo Chen, Zhang Weiming, Wang Hui
Department of Oncology.
Department of Orthopedic trauma, Affiliated Hospital of Binzhou Medical University, Binzhou, China.
Medicine (Baltimore). 2020 Jan;99(3):e18808. doi: 10.1097/MD.0000000000018808.
Malignant phyllodes tumors of the breast are rare, and there are currently no guidelines and a large number of clinical trials to guide the treatment of recurrence tumor. Here we reported a case of radiotherapy with apatinib for the treatment of recurrent malignant phyllodes tumor of the breast.
A 58-year-old patient with massive breast mass was admitted to our hospital. Two months after surgical treatment, the tumor recurred in the chest wall scar.
The histopathologic diagnoses was right breast malignant phyllodes tumor with chondrosarcomas and osteosarcomas in some areas.
The patient was first treated with surgery. Malignant phyllodes tumor recurred in the chest wall two months after surgery and was treated with radiotherapy and apatinib.
With surgery, radiotherapy and apatinib treatment, the patient still died within several months.
Apatinib and radiotherapy failed to obtain good therapeutic effect in the recurrence of breast malignant phyllodes tumor in this case.
乳腺恶性叶状肿瘤较为罕见,目前尚无指南及大量临床试验来指导复发性肿瘤的治疗。在此,我们报告了1例应用阿帕替尼联合放疗治疗复发性乳腺恶性叶状肿瘤的病例。
一名58岁的乳腺巨大肿块患者入住我院。手术治疗2个月后,肿瘤在胸壁瘢痕处复发。
组织病理学诊断为右乳腺恶性叶状肿瘤,部分区域伴有软骨肉瘤和骨肉瘤。
患者首先接受了手术治疗。术后2个月胸壁恶性叶状肿瘤复发,遂接受放疗及阿帕替尼治疗。
经过手术、放疗及阿帕替尼治疗,患者仍在数月内死亡。
在此病例中,阿帕替尼和放疗未能在乳腺恶性叶状肿瘤复发时取得良好的治疗效果。